Description: This is an unbranded Web site designed to help depression sufferers understand depression and take action. The includes simple, straight-to-the-point information. Upon arriving on the homepage, there’s a function to create adownloadable pdf about depression.

All the information included in the brochure can also be read online. Topics include: about depression, expectations, treatments, communication and an action plan. The site also includes a survey from which users can compare themselves with others who also took it. There’s also a resources section with links and telephone numbers.

Click here to visit the site.

Brand name: Missing Pieces
Generic name/category: disease awareness
Company: Lilly
Country/Market: USA, North America
Indication(s)/use: depression
Target: Consumers (DTC)
Tagline: Missing pieces
Medium: Internet
Size/duration: Microsite
Publication/Aired: 2009

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

Click on thumbnail to view the full-size ad on AdPharm

Objawy ADHD Wystepuja
Occurring ADHD symptoms

Generic name/category: Disease awareness
Company: Lilly
Country/Market: Poland, Europe
Indication(s)/use: Attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: Answers that matter.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczn – June 2009

Opipramol (Insidon, Pramolan) is a psychoactive drug widely used as an anxiolytic and antidepressant in Germany. Although it is a member of the tricyclic antidepressants (TCAs), opipramol's primary mechanism of action is much different in comparison. Most TCAs act as reuptake inhibitors, but opipramol does not, and instead acts as a sigma receptor agonist, among other properties.

More on Wikipedia

Brand name: Sympramol
Generic name/category: Opipramol, Anxiolytics, Tricyclic antidepressants
Company: Symphar
Country/Market: Poland, Europe
Indication(s)/use: Depression and Anxiety
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczna – September 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009

Visit AdPharm.net for more pharmaceutical ads

Voici Abilify, indiqu?© dans le traitement de la schizophr?©nie.
Parce que les sympt??mes n?©gatifs font aussi partie de la route.

Une att?©nuation des sympt??mes positifs et n?©gatifs a ?©t?© d?©montr?©e avec Abilify.

Nouveau Abilify.

Here's Abilify, indicated for the treatment of schizophrenia.
Because negative symptoms are also part of the road.

New Abilify.

Aripiprazole (marketed as Abilify, Abilify Discmelt; also known as BMS 337039, OPC-14597, and APZ) was approved by the Food and Drug Administration (FDA) on November 15, 2002 for the treatment of schizophrenia, the sixth atypical antipsychotic medication of its kind. More recently, it received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder, and as an adjunct for the treatment of major depressive disorder. Aripiprazole was developed by Otsuka in Japan; in the U.S., Otsuka America markets the drug jointly with Bristol-Myers Squibb.

More on Wikipedia

Brand name: Abilify
Generic name/category: Aripiprazole, Atypical antipsychotics, Piperazines
Company: Bristol-Myers Squibb (BMS)
Country/Market: Canada, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Le M?©decin du Qu?©bec – September 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009

Visit AdPharm.net for more pharmaceutical ads